Literature DB >> 8923542

Midlatency auditory evoked potentials and the startle response in the rat.

H Miyazato1, R D Skinner, N B Reese, J Mukawa, E Garcia-Rill.   

Abstract

The P13 midlatency auditory evoked potential in the rat is (i) sleep state dependent, (ii) undergoes rapid habituation and (iii) is blocked by the cholinergic antagonist scopolamine. As such, the P13 potential in the rat shows the same characteristics as the P1 (or P50) potential in the human. These potentials are thought to be mediated, at least in part, by the cholinergic arm of the reticular activating system. Previous studies have linked the reticular activating system with the startle response. The present study was undertaken to explore this relationship by simultaneously recording the P13 potential and the electromyographically recorded startle response using stimuli designed to elicit each response. Simultaneous recordings from the vertex and neck musculature following auditory click stimuli showed that: (i) the mean threshold of the P13 potential was 69.3 +/- 1.9 dB, while that for the startle response was 87.9 +/- 6.4 dB; (ii) the P13 potential was present during waking and paradoxical sleep, but absent during slow-wave sleep, while the startle response was present reliably only during waking; (iii) both responses habituated in response to paired stimuli, but the startle response was more habituated than the P13 potential; and (iv) both responses were facilitated by trains of stimuli in a similar manner. Recordings carried out from the auditory cortex verified that the primary cortical response had properties different from the P13 potential; i.e. it was present during all sleep-wake states, had a lower threshold and did not habituate rapidly. Finally, different patterns of startle responses were detected in the neck muscles. In every case, the P13 potential occurred during the middle, inhibitory phase of the startle response. These results suggest that the P13 potential and the startle response share response features, but the P13 potential appears to be more sensitive to auditory stimulation and to sleep-wake states. The startle response may be modulating descending systems by priming the spinal cord to respond in a "fight vs flight" fashion. On the other hand, the P13 response may be modulating ascending systems by triggering thalamocortical activity and resetting descending systems to allow novel motor strategies.

Entities:  

Mesh:

Year:  1996        PMID: 8923542     DOI: 10.1016/0306-4522(96)00176-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

Review 1.  The pedunculopontine tegmental nucleus: implications for a role in modulating spinal cord motoneuron excitability.

Authors:  Eugenio Scarnati; Tiziana Florio; Annamaria Capozzo; Giuseppina Confalone; Paolo Mazzone
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

2.  Vestibular evoked myogenic potentials in normal mice and Phex mice with spontaneous endolymphatic hydrops.

Authors:  Kianoush Sheykholeslami; Cliff A Megerian; Qing Y Zheng
Journal:  Otol Neurotol       Date:  2009-06       Impact factor: 2.311

3.  Effects of glutamate receptor agonists on the p13 auditory evoked potential and startle response in the rat.

Authors:  Christen Simon; Tiffany Wallace-Huitt; Priyenka Thapa; Robert D Skinner; Edgar Garcia-Rill
Journal:  Front Neurol       Date:  2011-01-27       Impact factor: 4.003

4.  State-dependent changes in auditory sensory gating in different cortical areas in rats.

Authors:  Renli Qi; Minghong Li; Yuanye Ma; Nanhui Chen
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

Review 5.  Arousal, motor control, and parkinson's disease.

Authors:  E Garcia-Rill; B Luster; S D'Onofrio; S Mahaffey
Journal:  Transl Neurosci       Date:  2015-10-05       Impact factor: 1.757

6.  Phasic activation of the locus coeruleus attenuates the acoustic startle response by increasing cortical arousal.

Authors:  Mingyu Yang; Nikos K Logothetis; Oxana Eschenko
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.